1. Multiple myeloma;Harousseau;Hematology ASCT Educ Program,2004
2. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997
3. Dose-intensive melphalan with stem cell support is superior to standard treatment in elderly myeloma patients;Palumbo;Blood,1999
4. Impact of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study;Lenhoff;Blood,2000
5. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/autotransplantation and who were conventionally treated;Blade;Blood,1996